Lack of Support for the Use of VMAT-2 Inhibitors for the Treatment of Tics in Tourette Syndrome-Reference-Cited by-同舟云学术

Lack of Support for the Use of VMAT-2 Inhibitors for the Treatment of Tics in Tourette Syndrome

Published:2021-10-18 Issue:10 Volume:4 Page:e2129704
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Baron Mark S.¹²

Affiliation:

1. Virginia Commonwealth University Parkinson’s Movement Disorders Center, Virginia Commonwealth University Health System, Richmond, Virginia

2. Southeast Parkinson’s Disease Research, Education and Clinical Center, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2785086/baron_2021_ic_210237_1633624187.64609.pdf

Reference7 articles.

1. Efficacy and safety of fixed-dose deutetrabenazine in children and adolescents for tics associated with Tourette syndrome: a randomized clinical trial.;Coffey;JAMA Netw Open,2021

2. Current management of tics and Tourette syndrome: behavioral, pharmacologic, and surgical treatments.;Billnitzer;Neurotherapeutics,2020

3. Tardive dyskinesia and new antipsychotics.;Correll;Curr Opin Psychiatry,2008

4. Does Tourette syndrome prevent tardive dyskinesia?;Müller-Vahl;Mov Disord,2011

5. Indirect tolerability comparison of deutetrabenazine and tetrabenazine for Huntington disease.;Claassen;J Clin Mov Disord,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gilles de la Tourette Syndrome;Reference Module in Neuroscience and Biobehavioral Psychology;2024